Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anthony Atallah, Marine Butin, Stéphanie Moret, Olivier Claris, Pascal Gaucherand & Muriel Doret-Dion. (2022) Fetal growth restriction: underdiagnosed condition with non-optimal screening. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 8237-8244.
Read now
Read now
Stella Capriglione, Francesco Plotti, Corrado Terranova, Ferdinando Antonio Gulino, Federica Di Guardo, Salvatore Lopez, Giuseppe Scaletta & Roberto Angioli. (2020) Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature. The Journal of Maternal-Fetal & Neonatal Medicine 33:4, pages 677-686.
Read now
Read now
Michela Torricelli, Maria Chiara Quadrifoglio & Felice Petraglia. (2008) Diagnostic role of inhibins and activins in adverse pregnancy outcomes. Expert Review of Obstetrics & Gynecology 3:5, pages 647-655.
Read now
Read now
Kevin Spencer, Christina K. H. Yu, George Rembouskos, Renu Bindra & Kypros H. Nicolaides. (2005) First Trimester Sex Hormone-Binding Globulin and Subsequent Development of Preeclampsia or Other Adverse Pregnancy Outcomes. Hypertension in Pregnancy 24:3, pages 303-311.
Read now
Read now
Articles from other publishers (25)
Georgia P. Wong, Faith Andres, Susan P. Walker, Teresa M. MacDonald, Ping Cannon, Tuong-Vi Nguyen, Emerson Keenan, Natalie J. Hannan, Stephen Tong & Tu'uhevaha J. Kaitu'u-Lino. (2022) Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia. Pregnancy Hypertension 27, pages 23-26.
Crossref
Crossref
Bhavisha A. Bakrania, Ana C. Palei, Umesh Bhattarai, Yingjie Chen, Joey P. Granger & Sajid Shahul. (2022) Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction. Cells 11:4, pages 742.
Crossref
Crossref
Leonel García Benavides, Diego Hernández Molina, Jessica L. Barajas Vega, Sylvia E. Totsuka Sutton, Fernando Grover Paéz, Francisco J. Hernández Mora, Ernesto J. Ramírez Lizardo, Sara Pascoe Gonzalez, David Cardona Müller & Ernesto G. Cardona Muñoz. 2017. Obstetrics. Obstetrics.
Lijie Li, Yanmei Zheng, Ying Zhu & Jianchun Li. (2016) Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia. Experimental and Therapeutic Medicine 12:4, pages 2515-2520.
Crossref
Crossref
R. Wijayarathna & D.M. de Kretser. (2016) Activins in reproductive biology and beyond. Human Reproduction Update 22:3, pages 342-357.
Crossref
Crossref
Hannah E.J. Yong, Padma Murthi, May H. Wong, Bill Kalionis, Judith E. Cartwright, Shaun P. Brennecke & Rosemary J. Keogh. (2015) Effects of normal and high circulating concentrations of activin A on vascular endothelial cell functions and vasoactive factor production. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 5:4, pages 346-353.
Crossref
Crossref
Hee Park, Sung Shim & Dong Cha. (2015) Combined Screening for Early Detection of Pre-Eclampsia. International Journal of Molecular Sciences 16:8, pages 17952-17974.
Crossref
Crossref
Agustin Conde-Agudelo, Roberto Romero & James M. Roberts. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
221
251
.
Melanie Griffin & Andrew H Shennan. (2014) Clinical applications of biomarkers in preeclampsia. Biomarkers in Medicine 8:4, pages 459-470.
Crossref
Crossref
Stefan C. Kane, Fabricio Da Silva Costa & Shaun P. Brennecke. (2014) New directions in the prediction of pre-eclampsia. Australian and New Zealand Journal of Obstetrics and Gynaecology 54:2, pages 101-107.
Crossref
Crossref
Stefan C. Kane, Fabricio da Silva Costa & Shaun Brennecke. (2014) First Trimester Biomarkers in the Prediction of Later Pregnancy Complications. BioMed Research International 2014, pages 1-6.
Crossref
Crossref
A Conde-Agudelo, AT Papageorghiou, SH Kennedy & J Villar. (2013) Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology 120:6, pages 681-694.
Crossref
Crossref
J. Yu, C. Z. Shixia, Y. Wu & T. Duan. (2011) Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia. Ultrasound in Obstetrics & Gynecology 37:5, pages 528-533.
Crossref
Crossref
C.S. von Kaisenberg & P. Hillemanns. (2009) Pränatale Diagnostik fetaler AnomalienPrenatal diagnosis of fetal anomalies. Der Gynäkologe 42:11, pages 865-871.
Crossref
Crossref
Agustin Conde-Agudelo, Roberto Romero & Marshall D. Lindheimer. 2009. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
189
211
.
K. Spencer, N. J. Cowans & K. H. Nicolaides. (2008) Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia. Ultrasound in Obstetrics and Gynecology 32:5, pages 622-626.
Crossref
Crossref
Kevin Spencer, Nicholas J. Cowans & Kypros H. Nicolaides. (2007) Low levels of maternal serum PAPP‐A in the first trimester and the risk of pre‐eclampsia. Prenatal Diagnosis 28:1, pages 7-10.
Crossref
Crossref
Irina Banzola, Antonio Farina, Manuela Concu, Akihiko Sekizawa, Yuditiya Purwosunu, Isabella Strada, Diego Arcelli, Giuliana Simonazzi, Elisabetta Caramelli & Nicola Rizzo. (2007) Performance of a panel of maternal serum markers in predicting preeclampsia at 11–15 weeks' gestation. Prenatal Diagnosis 27:11, pages 1005-1010.
Crossref
Crossref
Kevin Spencer, Nicholas J. Cowans, Ilana Chefetz, Joseph Tal, Ido Kuhnreich & Hamutal Meiri. (2007) Second‐trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre‐eclampsia. Prenatal Diagnosis 27:3, pages 258-263.
Crossref
Crossref
K. Spencer, N. J. Cowans, I. Chefetz, J. Tal & H. Meiri. (2006) First‐trimester maternal serum PP‐13, PAPP‐A and second‐trimester uterine artery Doppler pulsatility index as markers of pre‐eclampsia. Ultrasound in Obstetrics & Gynecology 29:2, pages 128-134.
Crossref
Crossref
Benjamin D. Hamar, Irina A. Buhimschi, Anna K. Sfakianaki, Christian M. Pettker, Lissa K. Magloire, Edmund F. Funai, Joshua A. Copel & Catalin S. Buhimschi. (2006) Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia. American Journal of Obstetrics and Gynecology 195:6, pages 1636-1645.
Crossref
Crossref
Claude Henri Diesch, Wolfgang Holzgreve, Sinuhe Hahn & Xiao Yan Zhong. (2006) Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenatal Diagnosis 26:13, pages 1267-1270.
Crossref
Crossref
K. Spencer, C. K. H. Yu, M. Savvidou, A. T. Papageorghiou & K. H. Nicolaides. (2006) Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free β-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound in Obstetrics and Gynecology 27:6, pages 658-663.
Crossref
Crossref
Eva M.L. Smets, Allerdien Visser, Attie T.J.I. Go, John M.G. van Vugt & Cees B.M. Oudejans. (2006) Novel biomarkers in preeclampsia. Clinica Chimica Acta 364:1-2, pages 22-32.
Crossref
Crossref
Aris T Papageorghiou & Nicole Roberts. (2005) Uterine artery Doppler screening for adverse pregnancy outcome. Current Opinion in Obstetrics & Gynecology 17:6, pages 584-590.
Crossref
Crossref